MAPT and Alzheimer disease: Tau pathology was found to be highly specific to the human pathology being induced, such that immunohistochemical findings revealed the presence of disease-specific inclusions using both anti-3R- and 4R-tau monoclonal antibodies directed against AD- and CBD-tau pathologies, respectively.